Geter-Douglass B - Search Results

1

(+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.

Shah JH, Kline RH, Geter-Douglass B, Izenwasser S, Witkin JM, Newman AH. Shah JH, et al. Among authors: geter douglass b. J Med Chem. 1996 Aug 16;39(17):3423-8. doi: 10.1021/jm960143p. J Med Chem. 1996. PMID: 8765528

2

(+/-)-(N-alkylamino)benzazepine analogs: novel dopamine D1 receptor antagonists.

Shah JH, Izenwasser S, Geter-Douglass B, Witkin JM, Newman AH. Shah JH, et al. Among authors: geter douglass b. J Med Chem. 1995 Oct 13;38(21):4284-93. doi: 10.1021/jm00021a018. J Med Chem. 1995. PMID: 7473556

3

Attenuation of the stimulant and convulsant effects of cocaine by 17-substituted-3-hydroxy and 3-alkoxy derivatives of dextromethorphan.

Zapata A, Gasior M, Geter-Douglass B, Tortella FC, Newman AH, Witkin JM. Zapata A, et al. Among authors: geter douglass b. Pharmacol Biochem Behav. 2003 Jan;74(2):313-23. doi: 10.1016/s0091-3057(02)01000-6. Pharmacol Biochem Behav. 2003. PMID: 12479950

4

Assessment of cocaine-like discriminative stimulus effects of dopamine D3 receptor ligands.

Acri JB, Carter SR, Alling K, Geter-Douglass B, Dijkstra D, Wikström H, Katz JL, Witkin JM. Acri JB, et al. Eur J Pharmacol. 1995 Aug 4;281(2):R7-9. doi: 10.1016/0014-2999(95)00411-d. Eur J Pharmacol. 1995. PMID: 7589197

5

Discriminative stimulus effects of R-(+)-3-amino-1-hydroxypyrrolid-2-one, [(+)-HA-966], a partial agonist of the strychnine-insensitive modulatory site of the N-methyl-D-aspartate receptor.

Witkin JM, Brave S, French D, Geter-Douglass B. Witkin JM, et al. Among authors: geter douglass b. J Pharmacol Exp Ther. 1995 Dec;275(3):1267-73. J Pharmacol Exp Ther. 1995. PMID: 8531091

6

Dizocilpine-like discriminative stimulus effects of competitive NMDA receptor antagonists in mice.

Geter-Douglass B, Witkin JM. Geter-Douglass B, et al. Psychopharmacology (Berl). 1997 Sep;133(1):43-50. doi: 10.1007/s002130050369. Psychopharmacology (Berl). 1997. PMID: 9335079

7

Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists.

Geter-Douglass B, Katz JL, Alling K, Acri JB, Witkin JM. Geter-Douglass B, et al. J Pharmacol Exp Ther. 1997 Oct;283(1):7-15. J Pharmacol Exp Ther. 1997. PMID: 9336302

8

gamma-Aminobutyric acidA agonists differentially augment gnawing induced by indirect-acting dopamine agonists in C57BL/6J mice.

Tirelli E, Geter-Douglass B, Witkin JM. Tirelli E, et al. Among authors: geter douglass b. J Pharmacol Exp Ther. 1998 Jan;284(1):116-24. J Pharmacol Exp Ther. 1998. PMID: 9435169

9

Behavioral effects and anticonvulsant efficacies of low-affinity, uncompetitive NMDA antagonists in mice.

Geter-Douglass B, Witkin JM. Geter-Douglass B, et al. Psychopharmacology (Berl). 1999 Oct;146(3):280-9. doi: 10.1007/s002130051118. Psychopharmacology (Berl). 1999. PMID: 10541728

10

NMDA antagonist properties of the putative antiaddictive drug, ibogaine.

Popik P, Layer RT, Fossom LH, Benveniste M, Geter-Douglass B, Witkin JM, Skolnick P. Popik P, et al. Among authors: geter douglass b. J Pharmacol Exp Ther. 1995 Nov;275(2):753-60. J Pharmacol Exp Ther. 1995. PMID: 7473163

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters